Dialysis industry news

Stories from the dialysis comunity across the globe.



UMF, American Renal Associates to form new dialysis clinic - The Lane Report PDF Print
<![CDATA[ .coverStorySummary {display:none;} ]]>

LOUISVILLE, Ky. (July 3, 2012) — University Medical Foundation Inc., a non-profit organization established to benefit the University of Louisville School of Medicine, is entering into a joint venture with American Renal Associates to form a new organization for providing kidney dialysis services to the people of the Louisville region.

University Kidney Center LLC began operations July 1 and is conducting business as the University of Louisville Renal Dialysis Center.

“This partnership allows us to continue to provide that high quality care, maintain our commitment to patients in the downtown area, and provide those services in modern facilities with additional amenities such as individual televisions and internet access,” said Eleanor Lederer, M.D., chief of nephrology at the University of Louisville.

The total transaction amount will be $21 million. UMF will hold 30 percent equity in the new joint venture.

“These funds will provide resources for support of the major missions of the medical school — research into the causes and treatment of kidney diseases,” Lederer said. “The partnership guarantees our trainees access to dialysis patients, which is a critical component of our teaching program in nephrology.”

The current dialysis unit has been an independent, single free-standing facility for nearly 50 years, making it a rarity among programs associated with an academic medical center. Recent changes in reimbursement by Medicare and Medicaid create the environment that such facilities do not have the resources necessary to continue to operate at a level of service expected by patients and to compete with the large private providers in the marketplace.

...

 
DaVita agrees to $55 million settlement - Reuters India PDF Print

9NEWS.com

DaVita agrees to $55 million settlement
Reuters India
(Reuters) - DaVita Inc, the largest operator of dialysis clinics in the United States, agreed to pay $55 million to settle a lawsuit raised by an individual in 2002 related to the use of anemia drug Epogen.The.
DaVita agrees to $55M settlement Denver Post
DaVita settles False Claims case for $55 million ModernHealthcare.com
DaVita Announces Woodard Qui Tam Settlement MarketWatch (press release)
Bangor Daily News  - Jags Report
all 34 news articles »

...

 
DaVita agrees to $55 million settlement - Reuters UK PDF Print

9NEWS.com

DaVita agrees to $55 million settlement
Reuters UK
(Reuters) - DaVita Inc, the largest operator of dialysis clinics in the United States, agreed to pay $55 million to settle a lawsuit raised by an individual in 2002 related to the use of anemia drug Epogen.The.
DaVita agrees to $55M settlement Denver Post
DaVita settles False Claims case for $55 million ModernHealthcare.com
DaVita Announces Woodard Qui Tam Settlement MarketWatch (press release)
Bangor Daily News  - Jags Report
all 34 news articles »

...

 
DaVita agrees to $55 million settlement - Reuters PDF Print

9NEWS.com

DaVita agrees to $55 million settlement
Reuters
(Reuters) - DaVita Inc, the largest operator of dialysis clinics in the United States, agreed to pay $55 million to settle a lawsuit raised by an individual in 2002 related to the use of anemia drug Epogen.The.
DaVita agrees to $55M settlement Denver Post
DaVita settles False Claims case for $55 million ModernHealthcare.com
DaVita Announces Woodard Qui Tam Settlement MarketWatch (press release)
Bangor Daily News  - Jags Report
all 34 news articles »

...

 
DaVita agrees to $55M settlement - Denver Post PDF Print

DaVita Inc. agreed to pay roughly $55 million in a settlement of a lawsuit filed by an individual in 2002 related to the anemia drug Epogen.

The dialysis-service provider said the agreement, which also includes the payment of attorneys fees, contains no findings of wrongdoing or admission of liability by the company. "DaVita and its affiliated physicians did nothing wrong and stand by their anemia management practices," the company said.

In a previous SEC filing, the company identified the individual as Ivey Woodard and said it was served with a complaint under the qui tam provisions of the federal False Claims Act.

DaVita also said the government investigated allegations raised by the individual; however, it chose not

to file claims against DaVita.

DaVita's shares closed at $97.62 on Monday and were inactive premarket. The stock is up 29% year-to-date.

Write to Saabira Chaudhuri at This e-mail address is being protected from spambots. You need JavaScript enabled to view it









...

 
<< Start < Prev 491 492 493 494 495 496 497 498 499 500 Next > End >>

Page 499 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.